Results 81 to 90 of about 9,749 (194)

Does basiliximab induction trigger lifethreatening ARDS and shock in young patients after kidney transplantation?

, 2013
Background. Kidney disease Improving Global Outcomes (KDIGO) guidelines strongly recommend administering an anti-IL-2R mAb (i.e. basiliximab) for induction in all kidney transplant recipients.
Broeders, Emine Nilufer, Creteur, Jacques, Abramowicz, Daniel, Mikhalski, Dimitri, Massart, Annick, Bejjani, Gilbert, Hoang, Anh Dung, Heenen, Sarah, De Backer, Daniel   +8 more
core   +1 more source

Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation

Journal of Transplantation, 2012
Dual induction with low doses of rabbit anti-human thymoglobulin (RATG) and basiliximab effectively and safely prevented allograft rejection in high-risk renal transplant recipients.
Alessia Gennarini, Paolo Cravedi, Maddalena Marasà, Annalisa Perna, Giovanni Rota, Mario Bontempelli, Silvio Sandrini, Giuseppe Remuzzi, Piero Ruggenenti   +8 more
doaj   +1 more source

Outcomes after anti-thymocyte globulin vs Basiliximab induction before deceased donor kidney transplants

, 2022
Background: Deceased donor kidney transplants represent an important source of renal replacement for the 100 000 patients initiating hemodialysis annually.
Haq, Muneeb Ul, Azhar, Kumael, Bakhthiyar, Syed Shahyan, Awan, Ahmed Arslan Yousuf, Abbas, Rana, Hafeez, Muhammad Saad, Murthy, Bhamidipati V Ramana   +6 more
core  

Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease

Frontiers in Immunology
BackgroundSteroid-resistant (SR) lower gastrointestinal (LGI) tract graft-versus-host disease (GVHD) is the predominant cause of morbidity and mortality from GVHD after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Zicheng Gao, Zhiping Fan, Zhi Liu, Xu Ye, Yunxin Zeng, Li Xuan, Fen Huang, Ren Lin, Jing Sun, Qifa Liu, Na Xu   +10 more
doaj   +1 more source

Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction

Journal of Immunology Research, 2015
Alemtuzumab, an anti-CD52 T-cell and B-cell depleting monoclonal antibody, is established for induction therapy in renal transplantation (KTx). We herein provide a comparative analysis between alemtuzumab and basiliximab induction therapy and correlate ...
Annemarie Weissenbacher, Theresa Hautz, Michael Kimelman, Rupert Oberhuber, Hanno Ulmer, Claudia Bösmüller, Manuel Maglione, Stefan Schneeberger   +7 more
doaj   +1 more source

¹²⁴I Radiolabeled Basiliximab for CD25-Targeted Immuno-PET Imaging of Activated T Cells

Activated T cells played critical roles in immunotherapy and adoptive T cell therapy, and a non-invasive imaging strategy can provide us useful information concerning the transportation, accumulation, and homing of T cells in vivo.
Qian Guo (107009), Hua Zhu (131619), Shuailiang Wang (10288124), Li Wen (169316), Futao Liu (8635164), Pei Wang (102036), Zilei Wang (7427981), Zhi Yang (124104)   +7 more
core   +1 more source

Non-Induction Basiliximab to Facilitate Renal Recovery via Temporary Tacrolimus Cessation in Cardiothoracic Transplant Patients

Medicines
Introduction: Reversible and irreversible nephrotoxicity are known complications of tacrolimus. Approaches to reduce the incidence of nephrotoxicity include the reduction or avoidance of tacrolimus but must be weighed against risk of rejection ...
Tanner A. Melton, Molly W. Fenske, Stacy A. Bernard, Kristin C. Cole, Kelly M. Pennington, Adley I. Lemke   +5 more
doaj   +1 more source

Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti-interleukin-2 receptor monoclonal antibody basiliximab.

, 2003
BACKGROUND: Repeated administration of chimeric or humanized monoclonal antibodies is generally well tolerated. Anti-idiotypic sensitization is rare and is considered to be of no clinical significance.
Abramowicz, Daniel, Goldman, Michel, Baudouin, Véronique, Crusiaux, Alain, Haddad, Elie, Loirat, Chantal, Schandené, Liliane   +6 more
core   +1 more source

Acute Respiratory Distress Syndrome in Young Postrenal Transplant Patients Receiving Basiliximab

Case Reports in Critical Care
Renal transplants have been increasing in number due to the rise in end-stage renal disease (ESRD) worldwide. Transplant is a good approach to management of renal disease, as it offers patients a better quality of life.
Kalkena Sivanesam, Scott K. Breeden, Stephen Brannan   +2 more
doaj   +1 more source

Low-dose RATG with or without basiliximab in renal transplantation : a matched-cohort observational study

, 2015
Background/Aims: In renal transplantation, peri-operative low-dose rabbit-antithymocyte-globulin (RATG) plus basiliximab induction prevented acute allograft rejection more effectively than post-operative RATG plus basiliximab induction.
G. Rota, A. Gennarini, LACANNA, FRANCESCO, B. Locatelli, D. Mastroluca, G. Remuzzi, G. Gentile, C. Somma, P. Ruggenenti   +8 more
core   +1 more source